Home / News / Pharmaceutical company Celgene settles suit for $280 million

Pharmaceutical company Celgene settles suit for $280 million

LOS ANGELES (AP) — Celgene Corp. has agreed to pay $280 million to settle a whistleblower lawsuit alleging the pharmaceutical company committed fraud promoting a drug with a notorious history that was re-purposed to treat leprosy and another therapy for unapproved cancer treatments, federal prosecutors announced Tuesday. The agreement settled a lawsuit in Los Angeles federal ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*